Background. The last decade has witnessed a sustained improvement of renal allograft survival that is partly explained by a better preservation of renal allograft function. This study describes time-dependent modifications of serum creatinine (SCr) during the first year after transplantation in the last decade in Spain and characterizes the predictive value of SCr on death-censored graft survival. Methods. A total of 3365 adult patients transplanted in 1990 (n ¼ 824), 1994 (n ¼ 1075) and 1998 (n ¼ 1466) with a functioning graft after the first year were included. Renal function deterioration during the first year was expressed as the difference between SCr at 1 year and SCr at 3 months. Results. Despite the projected renal allograft half-life, estimation was significantly higher in 1998 than in 1990 (17.7 vs 15.4 years, P ¼ 0.007), the SCr levels at 3 months were significantly lower in 1990 (1.59±0.64) than in 1998 (1.65±0.66). While SCr tended to worsen during the first year in 1990 (0.05±0.64) it improved in 1998 (À0.003±0.48), P ¼ 0.0001. The following variables were significantly associated with SCr at 3 months: donor age and sex, cause of death, recipient sex, time on dialysis, cold ischaemia time, delayed graft function, acute rejection, cytomegalovirus infection and reintervention for any reason. Renal function deterioration during the first year was associated with the presence of acute rejection and hepatitis C virus antibodies in the recipient. Conclusions. Despite poorer renal function at 3 months in 1998 than in 1990, renal allograft survival has improved in Spain between 1990 and 1998. This result is partly explained by a slower deterioration of renal function during the first year of follow-up.
Introduction
A steady improvement in long-term renal allograft survival has been observed in the United States between 1988 and 1996 [1] . In Spain, an improvement of renal allograft survival between 1990 and 1998 has been also described [2, 3] . These observations have challenged the old paradigm suggesting that graft attrition after the first year remains constant [4] . The reasons for such an improvement are not fully understood. In the United States, an improvement of 1 year serum creatinine (SCr) has paralleled the improvement of estimated mean renal allograft half-life in the last decade [5] . This observation suggests that improvement in allograft half-life is partly explained by a better preservation of renal function within the first year. The reason why renal function is being better preserved is not completely understood. On the one hand, donor age, a major determinant of renal function after transplantation has steadily increased, while the incidence of acute rejection, also a major contributing factor to poor renal allograft function, has decreased [2, 3, 6] . The introduction of new immunosuppressive agents may be partly responsible for this improvement. For example, patients treated with a calcineurin inhibitor associated with mycophenolate mofetil have a better long-term death-censored renal allograft survival than patients treated with a calcineurin inhibitor associated with azathioprine [7] .
The aim of the present study is to describe the evolution of SCr during the first year after transplantation in 1990, 1994 and 1998 in Spain and to identify variables associated with SCr at 3 months as well as with a deteriorating SCr between the third and 12th month. Finally, the predictive value of SCr at 3 months and the predictive value of SCr deterioration between the third and 12th month on death-censored graft survival are described.
Subjects and methods
We analysed patients included in the Spanish Chronic Allograft Nephropathy Study. As previously described [2, 3] , a cohort of 3365 adult patients transplanted in Spain during 1990, 1994 and 1998 with a functioning graft at 1 year were included.
SCr was recorded at 3 and 12 months of follow-up. In order to evaluate the evolution of SCr during the first year, the difference between SCr at 12 months and SCr at 3 months was calculated (dSCr). Creatinine clearance (CrCl) was estimated according to the Cockroft-Gault formula [8] and, similarly, the evolution of CrCl during the first year was expressed as the difference between CrCl at 12 and 3 months.
All included patients had a functioning graft at 12 months. The evolution of renal function after the first year was not evaluated to avoid the bias that graft loss could influence in the evaluation of renal function deterioration.
Statistics
Descriptive results are expressed as the mean±SD. Contingency tables were employed to describe categorical variables. Comparison of renal function between years of transplant was done by means of Kruskall-Wallis test.
Projected death-censored renal allograft half-life in 1990, 1994 and 1998 was calculated under the assumption of Weibull distributed graft survival times. Graft loss was defined as return to dialysis or retransplantation. Predictors of death censored graft survival were evaluated by means of a multiple Cox's proportional hazard regression. Only variables associated with graft survival in the univariate analysis were considered for the multivariate analysis.
Predictors of SCr at 3 months and at 1 year were evaluated by means of multiple regression analysis. Again, only variables associated with SCr in the univariate analysis were considered for the multivariate analysis. The association between variables is summarized by means of the beta coefficient. For continuous variables, beta represents the mean increase of SCr for an increase in the value of the predictor variable. For categorical variables, it represents the mean difference in creatinine between groups. All Pvalues were two-tailed and a P-value <0.05 was considered significant.
In order to analyse predictors of renal function deterioration between the third and 12th month a deteriorating renal function was defined as an increase of SCr !0.3 mg/100 ml. Otherwise it was assumed that renal function remained stable.
Results

Comparison of renal function between years of transplantation
Mean renal half-live and the 95% confidence interval was 15.4 years (14.1-16.8) in 1990, 13.5 years (12.1-14.9) in 1994 and 17.7 years (14.0-21.4) in 1998 (0.007).
The evolution of SCr and CrCl at 3 and 12 months during the study period is summarized in Table 1 . In 1990, SCr at 3 months was the lowest and it significantly increased in 1994 and 1998. However, between 3 and 12 months, the mean SCr worsened in 1990 and 1994, while it improved in 1998. CrCl calculation confirmed that renal function deteriorated between the third and 12th month in 1990 and 1994 while it improved by 1 ml/min in 1998.
Predictors of creatinine at 3 and 12 months
Results of the crude bivariate regression analysis of SCr at 3 and 12 months are not shown. Results of the multiple regression analysis are provided in Table 2 . The following variables were significantly associated with SCr at 3 months: donor age and sex, cause of death, recipient sex, time on dialysis, cold ischaemia time, delayed graft function, acute rejection, cytomegalovirus infection (CMV) and reintervention for any reason. The same variables were associated with SCr at 1 year with the exception of surgical complications and cold ischaemia time. 
Predictors of deterioration of renal function between the third and 12th month
The creatinine increase crude bivariate regression analyses results are not shown. Results of the multiple regression analyses are provided in Table 3 . The presence of acute rejection during the first 3 months and the presence of hepatitis C virus antibodies in the recipient were associated with a worsening of SCr between the third and 12th month, while prolonged cold ischaemia time and an increased serum glucose at 3 months were associated with an improvement of SCr between the third and 12th month.
Value of SCr and CrCl as a predictor of graft and patient survival
Cox regression analysis of graft and patient survival was performed to evaluate the predictive value of SCr at 3 months and the increase of SCr between the third and 12th month. For this purpose, the analysis was corrected for all variables associated with either patient or graft survival in the univariate analysis. As shown in Table 4 , both SCr at 3 months and dSCr between the third and 12th month were independently associated with graft and patient survival. A similar analysis was repeated to evaluate the predictive value of CrCl on graft and patient survival. CrCl at 3 months and the increase of CrCl between the third and 12th month were also predictors of graft survival. CrCl at 3 months but not the increase of CrCl between the third and 12th month of follow-up were predictors of patient survival.
Discussion
The introduction of new immunosuppressive agents has allowed a decrease in the incidence of acute rejection and consequently the incidence of graft failures during the first year [9] . However, it has until recently not been possible to demonstrate a modification in long-term renal allograft survival [1, 7] . In the United States, a steady improvement of long-term renal allograft survival has been documented in the last decade [1] . Although the reasons for such an improvement are only partially understood, this improvement can be partly explained by a better preserved renal function at 1 year of follow-up [5] . In the present study we show that there has also been an improvement in the projected renal allograft half-life estimate between 1990 and 1998 in Spain [2, 3] , SCr at 3 months of follow-up was higher in 1998 than in 1990. At 1 year of follow-up, SCr was not different between 1990 and 1998. Accordingly, our data do not support the idea that a better preservation of renal function during the first year is a necessary condition for a better renal allograft survival.
Interestingly, we observed that renal function deteriorated between the third and 12th month in 1990 but it significantly improved in 1998, showing that during the last decade the rate of renal functional deterioration has slowed down, at least during the first year. This observation suggests that a slower renal function deterioration despite a poorer renal function early after transplantation may partly explain the increased renal allograft life expectancy. This notion is reinforced by the observation that renal function at 3 months as well as the decrease of renal function between the third and 12th month after transplantation were independent predictors of long-term renal allograft survival. It is worthy to note that only patients with a functioning graft during the first year were included in our study. Thus, the rate of renal functional deterioration was available in all patients. This approach was preferred to the study of the evolution of renal function deterioration during a longer time period since the calculation of this parameter may be biased due to graft losses occurring after the first year. For example, in an epidemiological study, in which a glomerular filtration rate of 10 ml/min/1.73 m 2 was imputed for patients who returned to dialysis to calculate renal function deterioration, it was observed that patients with longer duration of follow-up had a less rapid decline in renal function. It was not possible to explain the source of this possible bias [10] .
Donor age and sex, cause of death, recipient sex, time on dialysis, cold ischaemia time, delayed graft function, acute rejection, CMV infection and reintervention for any reason were associated with SCr at 3 months. On the other hand, renal function deterioration during the first year of follow-up was associated with the presence of acute rejection and the presence of hepatitis C virus antibodies in the recipient. These data point out that rejection not only contributes to a decreased survival by an irreversible decline of renal function, but also because it is associated with an accelerated renal allograft function deterioration. This suggests that acute rejection triggers immune mechanisms that continue to damage the kidney far beyond the point where the acute rejection episode has apparently resolved. Our data also stress the importance of hepatitis C virus infection as a sustained insult to the graft contributing to accelerated renal functional deterioration [11, 12] .
SCr tended to improve between the third and 12th month in patients suffering from delayed renal allograft function. This finding probably reflects the fact that at 3 months the nadir creatinine has still not been achieved in patients with delayed renal allograft function. Also, SCr tended to improve after 3 months in patients with higher glucose levels. Again, this observation may reflect the detrimental effect of post-transplant hyperglycaemia on the recovery from ischaemia/reperfusion injury [13] and on acute rejection [14] .
Despite this, the present data do not allow a further exploration of the reasons why renal allograft survival has improved after the first year in Spain; the decrease in the incidence of acute rejection and in the prevalence of hepatitis C virus infection in transplanted patients may have contributed to this decrease of the rate of renal function deterioration in recent years.
In summary, this study shows that despite worsening of renal function at 3 months between 1990 and 1998, renal allograft survival after the first year has improved in Spain during the last decade. A slower decline of renal function, at least during the first year, may partly explain this improvement in renal allograft survival.
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